The earnings call highlighted significant revenue growth and strategic advancements, including a new loan facility and partnership progress. However, challenges remain with product margins and ongoing market uncertainties affecting system placements.
Company Guidance
During the Rapid Micro Biosystems Second Quarter 2025 Earnings Conference Call, the company provided guidance indicating a positive outlook for the remainder of the year despite some uncertainties. Total second-quarter revenue increased by 10% year-over-year to $7.3 million, with consumables and service revenue experiencing mid- to high-teens growth. The company reaffirmed its full-year revenue guidance of at least $32 million, although it anticipates finishing towards the low end of its previous guidance range of 21 to 25 system placements due to ongoing global trade dynamics affecting customer purchase decisions. Gross margins improved by 7 percentage points from the prior year to 4%, with expectations of further improvements in the fourth quarter. Operating expenses decreased by 6% year-over-year to $12.4 million, and the net loss per share improved to $0.27 from $0.29 in the previous year. The company also highlighted a new $45 million term loan facility to support long-term strategy execution, with the first $20 million tranche already drawn.
Revenue Growth
Total revenue increased 10% year-over-year to $7.3 million, with mid- to high-teens growth in both consumables and service. Recurring revenue increased 15%.
New Term Loan Facility
Announced a new $45 million, 5-year term loan facility with Trinity Capital, which supports long-term strategy and reinforces the ability to achieve positive cash flow.
Gross Margin Improvement
Gross margins improved by 7 percentage points from the prior year, marking the fourth consecutive quarter of positive gross margins.
MilliporeSigma Partnership
Meaningful progress in the commercial partnership with MilliporeSigma, including joint development of commercial opportunities and initiatives to lower product costs.
Rapid Micro Biosystems (RPID) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RPID Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 12, 2025
$3.26
$2.68
-17.79%
May 09, 2025
$2.45
$3.08
+25.71%
Feb 28, 2025
$3.31
$3.05
-7.85%
Nov 01, 2024
$1.08
$1.10
+1.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Rapid Micro Biosystems, Inc. Class A (RPID) report earnings?
Rapid Micro Biosystems, Inc. Class A (RPID) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).
What is Rapid Micro Biosystems, Inc. Class A (RPID) earnings time?
Rapid Micro Biosystems, Inc. Class A (RPID) earnings time is at Nov 06, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.